{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T18:37:01Z","timestamp":1794335821510,"version":"4.9.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T00:00:00Z","timestamp":1664150400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T00:00:00Z","timestamp":1664150400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["416375182"],"award-info":[{"award-number":["416375182"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["417577129"],"award-info":[{"award-number":["417577129"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000051","name":"U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute","doi-asserted-by":"publisher","award":["RM1 HG009490"],"award-info":[{"award-number":["RM1 HG009490"]}],"id":[{"id":"10.13039\/100000051","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R35 GM118158"],"award-info":[{"award-number":["R35 GM118158"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Biotechnol"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1038\/s41587-022-01473-1","type":"journal-article","created":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T16:03:44Z","timestamp":1664208224000},"page":"337-343","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":102,"title":["Engineered CRISPR prime editors with compact, untethered reverse transcriptases"],"prefix":"10.1038","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7537-7505","authenticated-orcid":false,"given":"Julian","family":"Gr\u00fcnewald","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bret R.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5438-1596","authenticated-orcid":false,"given":"Regan N.","family":"Szalay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter K.","family":"Cabeceiras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Woodilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliza Jane B.","family":"Holtz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9624-3976","authenticated-orcid":false,"given":"Karl","family":"Petri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5630-5645","authenticated-orcid":false,"given":"J. Keith","family":"Joung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,26]]},"reference":[{"key":"1473_CR1","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","volume":"576","author":"AV Anzalone","year":"2019","unstructured":"Anzalone, A. V. et al. Search-and-replace genome editing without double-strand breaks or donor DNA. Nature 576, 149\u2013157 (2019).","journal-title":"Nature"},{"key":"1473_CR2","doi-asserted-by":"publisher","first-page":"5635","DOI":"10.1016\/j.cell.2021.09.018","volume":"184","author":"PJ Chen","year":"2021","unstructured":"Chen, P. J. et al. Enhanced prime editing systems by manipulating cellular determinants of editing outcomes. Cell 184, 5635\u20135652 (2021).","journal-title":"Cell"},{"key":"1473_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29339-9","volume":"13","author":"X Li","year":"2022","unstructured":"Li, X. et al. Highly efficient prime editing by introducing same-sense mutations in pegRNA or stabilizing its structure. Nat. Commun. 13, 1669 (2022).","journal-title":"Nat. Commun."},{"key":"1473_CR4","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41477-021-01043-4","volume":"8","author":"W Xu","year":"2022","unstructured":"Xu, W. et al. A design optimized prime editor with expanded scope and capability in plants. Nat Plants 8, 45\u201352 (2022).","journal-title":"Nat Plants"},{"key":"1473_CR5","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41392-019-0072-7","volume":"4","author":"Y Wang","year":"2019","unstructured":"Wang, Y. et al. BE-PIGS: a base-editing tool with deaminases inlaid into Cas9 PI domain significantly expanded the editing scope. Signal Transduct. Target Ther. 4, 36 (2019).","journal-title":"Signal Transduct. Target Ther."},{"key":"1473_CR6","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/s41587-021-00901-y","volume":"40","author":"K Petri","year":"2022","unstructured":"Petri, K. et al. CRISPR prime editing with ribonucleoprotein complexes in zebrafish and primary human cells. Nat. Biotechnol. 40, 189\u2013193 (2022).","journal-title":"Nat. Biotechnol."},{"key":"1473_CR7","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1038\/nbt.3404","volume":"33","author":"BP Kleinstiver","year":"2015","unstructured":"Kleinstiver, B. P. et al. Broadening the targeting range of Staphylococcus aureus CRISPR\u2013Cas9 by modifying PAM recognition. Nat. Biotechnol. 33, 1293\u20131298 (2015).","journal-title":"Nat. Biotechnol."},{"key":"1473_CR8","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/nbt.3117","volume":"33","author":"SQ Tsai","year":"2015","unstructured":"Tsai, S. Q. et al. GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR\u2013Cas nucleases. Nat. Biotechnol. 33, 187\u2013197 (2015).","journal-title":"Nat. Biotechnol."},{"key":"1473_CR9","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/nature16526","volume":"529","author":"BP Kleinstiver","year":"2016","unstructured":"Kleinstiver, B. P. et al. High-fidelity CRISPR\u2013Cas9 nucleases with no detectable genome-wide off-target effects. Nature 529, 490\u2013495 (2016).","journal-title":"Nature"},{"key":"1473_CR10","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1006\/jmbi.2000.4281","volume":"305","author":"J Gu","year":"2001","unstructured":"Gu, J. et al. Substitution of Asp114 or Arg116 in the fingers domain of Moloney murine leukemia virus reverse transcriptase affects interactions with the template-primer resulting in decreased processivity. J. Mol. Biol. 305, 341\u2013359 (2001).","journal-title":"J. Mol. Biol."},{"key":"1473_CR11","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1110\/ps.16301","volume":"10","author":"D Das","year":"2001","unstructured":"Das, D. et al. A directed approach to improving the solubility of Moloney murine leukemia virus reverse transcriptase. Protein Sci. 10, 1936\u20131941 (2001).","journal-title":"Protein Sci."},{"key":"1473_CR12","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1080\/09168451.2017.1394790","volume":"81","author":"Y Katano","year":"2017","unstructured":"Katano, Y. et al. Generation of thermostable Moloney murine leukemia virus reverse transcriptase variants using site saturation mutagenesis library and cell-free protein expression system. Biosci. Biotechnol. Biochem. 81, 2339\u20132345 (2017).","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"1473_CR13","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.virusres.2008.01.001","volume":"134","author":"ML Cote","year":"2008","unstructured":"Cote, M. L. et al. Murine leukemia virus reverse transcriptase: structural comparison with HIV-1 reverse transcriptase. Virus Res. 134, 186\u2013202 (2008).","journal-title":"Virus Res."},{"key":"1473_CR14","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.str.2004.02.032","volume":"12","author":"D Das","year":"2004","unstructured":"Das, D. et al. The crystal structure of the monomeric reverse transcriptase from Moloney murine leukemia virus. Structure 12, 819\u2013829 (2004).","journal-title":"Structure"},{"key":"1473_CR15","doi-asserted-by":"publisher","first-page":"eabl9238","DOI":"10.1126\/scitranslmed.abl9238","volume":"14","author":"D Bock","year":"2022","unstructured":"Bock, D. et al. In vivo prime editing of a metabolic liver disease in mice. Sci. Transl. Med. 14, eabl9238 (2022).","journal-title":"Sci. Transl. Med."},{"key":"1473_CR16","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/nature14299","volume":"520","author":"F Ann Ran","year":"2015","unstructured":"Ann Ran, F. et al. In vivo genome editing using Staphylococcus aureus Cas9. Nature 520, 186\u2013191 (2015).","journal-title":"Nature"},{"key":"1473_CR17","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1126\/science.271.5255.1579","volume":"271","author":"SF Yu","year":"1996","unstructured":"Yu, S. F. et al. Human foamy virus replication: a pathway distinct from that of retroviruses and hepadnaviruses. Science 271, 1579\u20131582 (1996).","journal-title":"Science"},{"key":"1473_CR18","doi-asserted-by":"publisher","first-page":"598","DOI":"10.3390\/v11070598","volume":"11","author":"BM Wohrl","year":"2019","unstructured":"Wohrl, B. M. Structural and functional aspects of foamy virus protease-reverse transcriptase. Viruses 11, 598 (2019).","journal-title":"Viruses"},{"key":"1473_CR19","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1128\/JVI.73.3.2365-2375.1999","volume":"73","author":"B Berkhout","year":"1999","unstructured":"Berkhout, B. et al. Identification of an active reverse transcriptase enzyme encoded by a human endogenous HERV-K retrovirus. J. Virol. 73, 2365\u20132375 (1999).","journal-title":"J. Virol."},{"key":"1473_CR20","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.1371\/journal.ppat.0030010","volume":"3","author":"YN Lee","year":"2007","unstructured":"Lee, Y. N. et al. Reconstitution of an infectious human endogenous retrovirus. PLoS Pathog. 3, e10 (2007).","journal-title":"PLoS Pathog."},{"key":"1473_CR21","doi-asserted-by":"publisher","first-page":"3531","DOI":"10.1128\/jb.178.12.3531-3538.1996","volume":"178","author":"DA Mills","year":"1996","unstructured":"Mills, D. A. et al. Splicing of a group II intron involved in the conjugative transfer of pRS01 in lactococci. J. Bacteriol. 178, 3531\u20133538 (1996).","journal-title":"J. Bacteriol."},{"key":"1473_CR22","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1261\/rna.039743.113","volume":"19","author":"S Mohr","year":"2013","unstructured":"Mohr, S. et al. Thermostable group II intron reverse transcriptase fusion proteins and their use in cDNA synthesis and next-generation RNA sequencing. RNA 19, 958\u2013970 (2013).","journal-title":"RNA"},{"key":"1473_CR23","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1261\/rna.2126203","volume":"9","author":"L Dai","year":"2003","unstructured":"Dai, L. et al. ORF-less and reverse-transcriptase-encoding group II introns in archaebacteria, with a pattern of homing into related group II intron ORFs. RNA 9, 14\u201319 (2003).","journal-title":"RNA"},{"key":"1473_CR24","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1261\/rna.7181105","volume":"11","author":"FJ Blocker","year":"2005","unstructured":"Blocker, F. J. et al. Domain structure and three-dimensional model of a group II intron-encoded reverse transcriptase. RNA 11, 14\u201328 (2005).","journal-title":"RNA"},{"key":"1473_CR25","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.molcel.2017.10.024","volume":"68","author":"JL Stamos","year":"2017","unstructured":"Stamos, J. L. et al. Structure of a thermostable group II intron reverse transcriptase with template-primer and its functional and evolutionary implications. Mol. Cell 68, 926\u2013939 (2017).","journal-title":"Mol. Cell"},{"key":"1473_CR26","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/nsmb.3224","volume":"23","author":"C Zhao","year":"2016","unstructured":"Zhao, C. et al. Crystal structures of a group II intron maturase reveal a missing link in spliceosome evolution. Nat. Struct. Mol. Biol. 23, 558\u2013565 (2016).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"1473_CR27","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1261\/rna.063479.117","volume":"24","author":"C Zhao","year":"2018","unstructured":"Zhao, C. et al. An ultraprocessive, accurate reverse transcriptase encoded by a metazoan group II intron. RNA 24, 183\u2013195 (2018).","journal-title":"RNA"},{"key":"1473_CR28","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/nprot.2015.053","volume":"10","author":"LA Kelley","year":"2015","unstructured":"Kelley, L. A. et al. The Phyre2 web portal for protein modeling, prediction and analysis. Nat. Protoc. 10, 845\u2013858 (2015).","journal-title":"Nat. Protoc."},{"key":"1473_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22295-w","volume":"12","author":"P Liu","year":"2021","unstructured":"Liu, P. et al. Improved prime editors enable pathogenic allele correction and cancer modelling in adult mice. Nat. Commun. 12, 2121 (2021).","journal-title":"Nat. Commun."},{"key":"1473_CR30","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1038\/s41587-021-01112-1","volume":"40","author":"B Liu","year":"2022","unstructured":"Liu, B. et al. A split prime editor with untethered reverse transcriptase and circular RNA template. Nat. Biotechnol. 40, 779\u2013786 (2022).","journal-title":"Nat. Biotechnol."},{"key":"1473_CR31","doi-asserted-by":"publisher","first-page":"6450","DOI":"10.1093\/nar\/gkv601","volume":"43","author":"DJ Truong","year":"2015","unstructured":"Truong, D. J. et al. Development of an intein-mediated split\u2013Cas9 system for gene therapy. Nucleic Acids Res. 43, 6450\u20136458 (2015).","journal-title":"Nucleic Acids Res."},{"key":"1473_CR32","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41551-019-0501-5","volume":"4","author":"JM Levy","year":"2020","unstructured":"Levy, J. M. et al. Cytosine and adenine base editing of the brain, liver, retina, heart and skeletal muscle of mice via adeno-associated viruses. Nat. Biomed. Eng. 4, 97\u2013110 (2020).","journal-title":"Nat. Biomed. Eng."},{"key":"1473_CR33","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1080\/15476286.2019.1639310","volume":"16","author":"N Toro","year":"2019","unstructured":"Toro, N. et al. Multiple origins of reverse transcriptases linked to CRISPR\u2013Cas systems. RNA Biol. 16, 1486\u20131493 (2019).","journal-title":"RNA Biol."},{"key":"1473_CR34","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1038\/nbt1088-1204","volume":"6","author":"TP Hopp","year":"1988","unstructured":"Hopp, T. P. et al. A short polypeptide marker sequence useful for recombinant protein identification and purification. Bio\/Technology 6, 1204\u20131210 (1988).","journal-title":"Bio\/Technology"},{"key":"1473_CR35","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1101\/gr.128124.111","volume":"22","author":"N Rohland","year":"2012","unstructured":"Rohland, N. et al. Cost-effective, high-throughput DNA sequencing libraries for multiplexed target capture. Genome Res. 22, 939\u2013946 (2012).","journal-title":"Genome Res."},{"key":"1473_CR36","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/nmeth.1318","volume":"6","author":"DG Gibson","year":"2009","unstructured":"Gibson, D. G. et al. Enzymatic assembly of DNA molecules up to several hundred kilobases. Nat. Methods 6, 343\u2013345 (2009).","journal-title":"Nat. Methods"},{"key":"1473_CR37","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature14592","volume":"523","author":"BP Kleinstiver","year":"2015","unstructured":"Kleinstiver, B. P. et al. Engineered CRISPR\u2013Cas9 nucleases with altered PAM specificities. Nature 523, 481\u2013485 (2015).","journal-title":"Nature"},{"key":"1473_CR38","doi-asserted-by":"publisher","first-page":"562","DOI":"10.15252\/emmm.201505047","volume":"7","author":"M Gramlich","year":"2015","unstructured":"Gramlich, M. et al. Antisense\u2010mediated exon skipping: a therapeutic strategy for titin\u2010based dilated cardiomyopathy. EMBO Mol. Med. 7, 562\u2013576 (2015).","journal-title":"EMBO Mol. Med."},{"key":"1473_CR39","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/s41587-019-0032-3","volume":"37","author":"K Clement","year":"2019","unstructured":"Clement, K. et al. CRISPResso2 provides accurate and rapid genome editing sequence analysis. Nat. Biotechnol. 37, 224\u2013226 (2019).","journal-title":"Nat. Biotechnol."},{"key":"1473_CR40","unstructured":"Gr\u00fcnewald, J. et al. Datasets. Sequence Read Archive (SRA). http:\/\/www.ncbi.nlm.nih.gov\/bioproject\/861237 (2022)."}],"container-title":["Nature Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41587-022-01473-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41587-022-01473-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41587-022-01473-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T17:10:40Z","timestamp":1678900240000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41587-022-01473-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,26]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["1473"],"URL":"https:\/\/doi.org\/10.1038\/s41587-022-01473-1","relation":{},"ISSN":["1087-0156","1546-1696"],"issn-type":[{"value":"1087-0156","type":"print"},{"value":"1546-1696","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,26]]},"assertion":[{"value":"13 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.K.J. and two other investigators who work on the National Institutes of Health award supporting this research, but are not authors on this publication, are co-founders of and have a financial interest in SeQure Dx, Inc., a company developing technologies for gene editing target profiling. J.K.J. also has, or had during the course of this research, financial interests in several companies developing gene editing technology: Beam Therapeutics, Blink Therapeutics, Chroma Medicine, Editas Medicine, EpiLogic Therapeutics, Excelsior Genomics, Hera Biolabs, Monitor Biotechnologies, Nvelop Therapeutics (f\/k\/a ETx, Inc.), Pairwise Plants, Poseida Therapeutics and Verve Therapeutics. J.K.J.\u02bcs interests were reviewed and are managed by Massachusetts General Hospital and Mass General Brigham in accordance with their conflict of interest policies. J.K.J. is a co-inventor on various patents and patent applications that describe gene editing and epigenetic editing technologies. K.P. has a financial interest in SeQure Dx, Inc. K.P.\u02bcs interests and relationships have been disclosed to Massachusetts General Hospital and Mass General Brigham in accordance with their conflict of interest policies. P.K.C. is a paid consultant to and has financial interests in Nvelop Therapeutics (f\/k\/a ETx, Inc.). J.G., B.R.M. and J.K.J. are co-inventors on a patent application that has been filed by Mass General Brigham\/Massachusetts General Hospital on engineered bipartite PE architectures, reduced size PEs and non-MMLV-RT PE architectures.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}